Evidence map›Paper›PMID 35089944›Full record

ArticlePloS one2022

Seroprevalence of SARS-CoV-2 antibodies and knowledge, attitude and practice toward COVID-19 in the Republic of Srpska-Bosnia & Herzegovina: A population-based study.

Biljana Mijović, Srdjan Mašić, Miroslav Petković, Darija Knežević, Jela Aćimović, Jelena Djaković-Dević, Dragana Puhalo-Sladoje, Branislav Zeljković, Dragan Spaić, Dejan Bokonjić and 1 more

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Biljana MijovićFaculty of Medicine, Department of Primary Health Care and Public Health, University of East Sarajevo, Foča, the Republic of Srpska, Bosnia and Herzegovina.
Srdjan MašićFaculty of Medicine, Department of Primary Health Care and Public Health, University of East Sarajevo, Foča, the Republic of Srpska, Bosnia and Herzegovina.ORCID 0000-0001-8852-2054
Miroslav PetkovićFaculty of Medicine, University of Banja Luka, Centre for Biomedical Research, Banja Luka, the Republic of Srpska, Bosnia and Herzegovina.
Darija KneževićFaculty of Medicine, University of Banja Luka, Centre for Biomedical Research, Banja Luka, the Republic of Srpska, Bosnia and Herzegovina.
Jela AćimovićPublic Health Institute of the Republic of Srpska, Banja Luka, the Republic of Srpska, Bosnia and Hercegovina.
Jelena Djaković-DevićPublic Health Institute of the Republic of Srpska, Banja Luka, the Republic of Srpska, Bosnia and Hercegovina.
Dragana Puhalo-SladojeFaculty of Medicine, University of East Sarajevo, Centre for Biomedical Research, Foca, the Republic of Srpska, Bosnia and Herzegovina.
Branislav ZeljkovićPublic Health Institute of the Republic of Srpska, Banja Luka, the Republic of Srpska, Bosnia and Hercegovina.
Dragan SpaićFaculty of Medicine, Department of Primary Health Care and Public Health, University of East Sarajevo, Foča, the Republic of Srpska, Bosnia and Herzegovina.
Dejan BokonjićFaculty of Medicine, Department of Paediatrics, University of East Sarajevo, Foča, the Republic of Srpska, Bosnia and Herzegovina.
Ranko ŠkrbićFaculty of Medicine, University of Banja Luka, Centre for Biomedical Research, Banja Luka, the Republic of Srpska, Bosnia and Herzegovina.ORCID 0000-0002-6643-1781

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the study was to assess the seroprevalence of SARS-CoV-2 in the Republic of Srpska, Bosnia and Herzegovina, and to analyse the knowledge, attitudes and practices of the population toward COVID-19. This population-based study was conducted in a group of 1,855 randomly selected individuals from all municipalities from 1 December 2020 to 15 January 2021. All individuals were asked to sign a consent form and to fill in a questionnaire, following which a blood samples were collected. Total anti-SARS-CoV-2 antibodies were determined in serum specimens using the total Ab ELISA assay. The overall seroprevalence rate was 40.3%. Subjects aged <65 years were 2.06 times more likely to be seropositive than those aged ≥65, and 30% of seropositive individuals presented no COVID-19 symptoms. The household members of seropositive individuals were 2.24 times more likely to develop COVID-19 symptoms than the household members of seronegative individuals. More than 95% of respondents believe that preventive measures are very important to control the infection transmission. Majority of respondents wear the masks properly, maintain the required physical distance whenever possible and wash hands with soap. Nearly 50% of individuals were of the opinion that the vaccine could prevent the infection. This study showed that an overall SARS-CoV-2 seropositivity rate by the middle of January 2021 was very high. Attitudes and practices regarding the COVID-19 indicate that additional efforts should be taken in order to improve the health education with a focus on preventive measures and vaccination.

Indexed as

Health Knowledge, Attitudes, PracticeAdolescentAdultAgedAged, 80 and overAntibodies, ViralBosnia and HerzegovinaChildCOVID-19FemaleHumansInfantMaleMiddle AgedSARS-CoV-2Seroepidemiologic StudiesAntibodies, Viral

Identifiers

PMID35089944
PMCPMC8797215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.